AP report: Marty Makary resigning as Trump's FDA chief
Summary
Dr. Marty Makary is resigning as head of the Food and Drug Administration (FDA) after just over a year. His time leading the agency was marked by internal conflicts, staff departures, and criticism from various political and industry groups connected to President Donald Trump’s administration.Key Facts
- Dr. Marty Makary, an outspoken critic of COVID-19 measures, led the FDA for slightly more than a year.
- His leadership faced complaints from health industry executives, anti-abortion activists, and allies of President Trump.
- Many senior FDA career officials resigned, retired, or were pushed out during the first year of the Trump administration’s second term.
- Makary’s deputy, Dr. Vinay Prasad, left the agency twice amid tensions with drugmakers and patient advocacy groups.
- The FDA experienced low morale, staff frustration, and leaks about internal dysfunction.
- Makary promoted initiatives to speed up drug reviews and use artificial intelligence in drug evaluations.
- Critics, including anti-abortion groups, accused Makary of delaying the review of the abortion pill mifepristone.
- Vaping industry leaders said Makary blocked approval of flavored e-cigarette products important to their business.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.